This index is particularly useful for healthcare professionals, researchers, and individuals seeking detailed information about specific branded pharmaceutical product.
Monographs serve as essential reference for clinical particulars such as drug composition and administration guidelines, indications, contraindications and adverse reactions.
| Document | Type | Information Source | |
|---|---|---|---|
| ZYBAN Prolonged release tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ZYCLARA Cream | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ZYDELIG Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYDENA Tablet | MPI, Generic | Web Search | |
| ZYDOL Soluble tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ZYDOL Solution for injection or infusion | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ZYFLO Film-coated tablet | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| ZYKADIA Hard capsule | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYLET Ophthalmic suspension | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ZYLLT Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYLOPRIM Tablet | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| ZYLORIC Tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ZYMAR 0.3% w/v Ophthalmic solution | MPI, CA: SPM | Health Products and Food Branch (CA) | |
| ZYMAXID Ophthalmic solution | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ZYNLONTA Powder for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYNQUISTA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYNTEGLO Dispersion for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYNYZ Concentrate for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYNYZ Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ZYPREXA Coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYPREXA Powder for solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYPREXA Tablet / Tablet, orally disintegrating / Powder for solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ZYRTEC Film-coated tablet / Oral drops / Oral solution | MPI, Generic | Health Sciences Authority (SG) | |
| ZYRTEC-D Prolonged release tablet | MPI, EU: SmPC | Marketing Authorisation Holder | |
| ZYTIGA Film-coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ZYTIGA Tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZYTRAM XL Controlled release tablet | MPI, CA: SPM | Health Products and Food Branch (CA) | |
| ZYVOX Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ZYVOXID Tablet / Solution for Infusion / Granules for suspension | MPI, Generic | Health Products Regulatory Authority (ZA) |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.